Results 101 to 110 of about 96,798 (264)

A framework for integrating health‐related social needs education into electronic health record clinical pathways

Journal of Hospital Medicine, EarlyView.
Abstract Health‐related social needs (HRSN) significantly influence patient outcomes, yet they are rarely integrated into point‐of‐care decision‐making. We developed a process to embed HRSN‐informed and HRSN‐targeted care recommendations directly into three electronic health record‐integrated high‐use clinical pathways—cirrhosis, diabetes, and ...
Karthik Warke Rohatgi, Siddhi Nadkarni, Nisarg Shah, Lou Hart, Dan Heacock, Shaili Gupta   +5 more
wiley   +1 more source

Safety of bioelectrical impedance analysis in patients with cardiac implantable electronic devices: A systematic review

Journal of Parenteral and Enteral Nutrition, EarlyView.
Abstract Background Bioelectrical impedance analysis is widely used in clinical settings to assess body composition, contributes to the management of various health conditions. However, for patients with cardiac implantable electronic devices, such as pacemakers and implantable cardioverter‐defibrillators, concerns about electromagnetic interference ...
H. Zweers, Z. Zhao, E. Noom, W. Visser, I. Jans, L. Willems, M. Verhoeven, D. A. Theuns, H. Jager‐Wittenaar   +8 more
wiley   +1 more source

“Atrial torsades de pointes” Induced by Low-Energy Shock From Implantable-Cardioverter Defibrillator

Indian Pacing and Electrophysiology Journal, 2013
A 58 year-old-patient developed an episode of polymorphic atrial tachycardia which looked like "atrial torsades de pointes" after a 5J shock from implantable cardioverter defibrillator.
Ilknur Can, MD, Venkatakrishna Tholakanahalli, MD, FHRS   +1 more
doaj   +1 more source

Radial outer retina reflectivity (RORR) sign in LAMP2‐associated retinopathy

Acta Ophthalmologica, EarlyView.
Abstract Purpose To describe the radial outer retina reflectivity (RORR) sign in patients carrying pathogenic variants in the X‐linked lysosome‐associated membrane protein‐2 (LAMP2) gene and to review the histologic characteristics of LAMP2 expression in the human retina.
Rachael C. Heath Jeffery, Bohdan Kousal, Ulrike Grünert, Christine A. Curcio, Svetlana Cherepanoff, Tina M. Lamey, Michel Michaelides, Chrysanthi Tsika, Isabelle Chow, Omar A. Mahroo, Seungmin Lee, Martin Meliska, Milos Kubanek, Jakub Sikora, Siying Lin, Raymond C. B. Wong, Petra Liskova, Fred K. Chen   +17 more
wiley   +1 more source

Oral factor Xa inhibitors for stroke prevention in patients with device-detected atrial fibrillation – Recent evidence from the NOAH-AFNET 6 and ARTESiA trials

Cardiologia Hungarica
Device-detected atrial fibrillation (AF), also known as atrial high rate episodes, is a frequent finding in patients with a cardiac implantable electronic device such as a pacemaker, or an implantable cardioverter-defibrillator or loop recorder.
Alexander P. Benz, William F. McIntyre
doaj   +1 more source

First‐in‐human outpatient management of recurrent NMIBC with the Multi4 instrument

BJU International, EarlyView.
Objectives To evaluate the feasibility, safety and diagnostic performance of outpatient management of recurrent non‐muscle‐invasive bladder cancer (NMIBC) under local anaesthesia using the Multi4 instrument, a series of preclinical studies were performed followed by a first‐in‐human clinical investigation.
Miden Melle‐Hannah, Henrik Kjölhede, Henrik Bäckdahl, Martin E. Johansson, Joakim Håkansson   +4 more
wiley   +1 more source

Exploring the patients’ experiences of living with a subcutaneous implantable cardioverter defibrillator

, 2018
Background: The implantable cardioverter defibrillator provides effective treatment for the prevention of sudden cardiac arrest but significant risks associated with transvenous implantation persist.
Alyssa Shook, Jacqueline Forman, Jennifer Baumbusch, Heather Jackson, Jen Lindenberg, Jamil Bashir   +5 more
core   +1 more source

The first cardioverter defibrillator implanted in Central Africa

The Pan African Medical Journal, 2016
Sudden cardiac deaths, which account for approximately 350 000 deaths each year, is a major health care problem. Antiarrhythmic drugs have not been reliable in preventing sudden cardiac death. Although -blockers, angiotensin-converting enzyme inhibitors,
Tantchou Tchoumi Jacques Cabral, Appolonia Budzee, Gianfranco Butera   +2 more
doaj   +1 more source

Refining the treatment of immune checkpoint inhibitor–associated myocarditis: Challenges, innovations and rechallenge considerations

British Journal of Pharmacology, EarlyView.
Immune checkpoint inhibitor (ICI)‐associated myocarditis has emerged as a severe and clinically complex immune‐related toxicity that poses significant challenges for therapeutic decision‐making in routine cardio‐oncological care. High‐dose corticosteroids remain the first‐line therapy, yet their timing, dosage and tapering require careful clinical ...
Raluca I. Mincu, Lisa Zimmer, Dimitra Vlachopoulou, Elias Haj‐Yehia, Julia Hoffmann, Lars Michel, Elisabeth Livingstone, Dirk Schadendorf, Alpaslan Tasdogan, Matthias Totzeck, Tienush Rassaf   +10 more
wiley   +1 more source

Arrhythmias associated with immune checkpoint inhibitor therapy—A clinical perspective

British Journal of Pharmacology, EarlyView.
Immune checkpoint inhibitors (ICIs) have transformed cancer therapy but are associated with a growing spectrum of cardiovascular immune‐related adverse events. Among these, arrhythmias represent a rare yet potentially life‐threatening complication. ICI‐induced arrhythmias encompass a wide clinical spectrum, including atrial arrhythmias, conduction ...
Dong Wang, Melanie Ricke‐Hoch, David Duncker, Johann Bauersachs, Dominik Berliner   +4 more
wiley   +1 more source